Physician profile
Mariah Charette
NPI 1730770793
$760.80
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $241 · 2022: $489 · 2024: $30.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $289.11 | 2021-2022 | |
| Abbvie INC. | $156.63 | 2022 | |
| Lilly USA, LLC | $118.88 | 2022 | |
| Nestle Healthcare Nutrition INC. | $51.32 | 2022 | |
| Exact Sciences Corporation | $30.57 | 2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.68 | 2022 | |
| Amneal Pharmaceuticals LLC | $24.38 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.39 | 2021 | |
| Vanda Pharmaceuticals INC. | $13.26 | 2022 | |
| Sanofi-Aventis U.S. LLC | $11.68 | 2022 | |
| Amgen INC. | $11.55 | 2022 | |
| Organon LLC | $10.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariah Charette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.